NURO Neurometrix Inc
NeuroMetrix Inc manufactures and sells wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests that help patients and physicians manage chronic pain, nerve diseases, and sleep disorders.
$1.91 +0.03 (1.60%)
As of 01/24/2023 16:00:00 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Medical Instruments & Supplies
Index country: USA
Country of incorporation: USA
IPO date: 07/22/2004
Outstanding shares: 7,757,226
Average volume: 49,036
Market cap: $14,273,296
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol:
Valuation (See tab for details)
PE ratio: -4.66
PB ratio: 0.61
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%